Factors influencing treatment adherence in hypertension and HIV management in South Africa: A comparative literature review.
HIV
adherence
compliance
counselling
health knowledge
hypertension
patient education
Journal
South African family practice : official journal of the South African Academy of Family Practice/Primary Care
ISSN: 2078-6204
Titre abrégé: S Afr Fam Pract (2004)
Pays: South Africa
ID NLM: 9701104
Informations de publication
Date de publication:
29 06 2022
29 06 2022
Historique:
received:
17
10
2021
accepted:
11
04
2022
revised:
29
03
2022
entrez:
8
9
2022
pubmed:
9
9
2022
medline:
11
9
2022
Statut:
epublish
Résumé
Hypertension (HTN) is the most significant risk factor for cardiovascular disease (CVD) in South Africa (SA), with one in three people over the age of 25 suffering from HTN. Whilst human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS) are the leading causes of death in South Africa, CVD is in the top 10 causes of death, demonstrating the importance of detecting and controlling blood pressure early on. This study aimed to review adherence factors to antihypertensive medication and antiretroviral therapy (ART) and evaluate the resulting factors influencing adherence discrepancies within the South African population. A comprehensive literature review was carried out. PubMed, ScienceDirect, Cochrane and Embase were searched for English publications between 2000 and 2021. A total of 50 articles covering quantitative and qualitative studies were included. Many studies identified poor adherence levels to antihypertensive treatment, reaching a substandard adherence rate of 41.9%, whilst most studies on the HIV-positive population reported good levels of adherence, with adherence rates of more than 90%. Being of the male gender, advanced age, low socioeconomic status and a low level of education were associated with unsatisfactory adherence rates in both groups. Within the HIV group, more participants had better knowledge concerning the extent of their disease and its required treatments. The results present substandard adherence levels to antihypertensives compared with antiretroviral (ARV) adherence, despite the influence of more non-adherence factors in the HIV group. The authors recommend better adherence counselling for patients with HTN during every clinic visit, regular healthcare worker training and the implementation of ART adherence programmes in patients with hypertension.
Sections du résumé
BACKGROUND
Hypertension (HTN) is the most significant risk factor for cardiovascular disease (CVD) in South Africa (SA), with one in three people over the age of 25 suffering from HTN. Whilst human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS) are the leading causes of death in South Africa, CVD is in the top 10 causes of death, demonstrating the importance of detecting and controlling blood pressure early on. This study aimed to review adherence factors to antihypertensive medication and antiretroviral therapy (ART) and evaluate the resulting factors influencing adherence discrepancies within the South African population.
METHODS
A comprehensive literature review was carried out. PubMed, ScienceDirect, Cochrane and Embase were searched for English publications between 2000 and 2021.
RESULTS
A total of 50 articles covering quantitative and qualitative studies were included. Many studies identified poor adherence levels to antihypertensive treatment, reaching a substandard adherence rate of 41.9%, whilst most studies on the HIV-positive population reported good levels of adherence, with adherence rates of more than 90%. Being of the male gender, advanced age, low socioeconomic status and a low level of education were associated with unsatisfactory adherence rates in both groups. Within the HIV group, more participants had better knowledge concerning the extent of their disease and its required treatments.
CONCLUSION
The results present substandard adherence levels to antihypertensives compared with antiretroviral (ARV) adherence, despite the influence of more non-adherence factors in the HIV group. The authors recommend better adherence counselling for patients with HTN during every clinic visit, regular healthcare worker training and the implementation of ART adherence programmes in patients with hypertension.
Identifiants
pubmed: 36073101
doi: 10.4102/safp.v64i1.5434
pmc: PMC10064525
doi:
Substances chimiques
Anti-Retroviral Agents
0
Antihypertensive Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1-e10Références
BMC Public Health. 2010 Mar 05;10:111
pubmed: 20205721
BMC Public Health. 2011 Feb 08;11:88
pubmed: 21303548
South Afr J HIV Med. 2020 Sep 16;21(1):1115
pubmed: 33101723
Res Social Adm Pharm. 2019 Apr;15(4):469-473
pubmed: 29803539
Cardiovasc J Afr. 2011 Jul-Aug;22(4):186-90
pubmed: 21881683
J Clin Nurs. 2011 Mar;20(5-6):692-705
pubmed: 21320198
AIDS Behav. 2019 Aug;23(8):2121-2129
pubmed: 30259346
BMJ. 2013 Jun 13;346:f3481
pubmed: 23766483
BMC Public Health. 2008 Feb 18;8:63
pubmed: 18282286
Circulation. 2016 Feb 9;133(6):592-600
pubmed: 26769742
Clin Med Insights Womens Health. 2016 May 12;9(Suppl 1):9-16
pubmed: 27199580
AIDS Care. 2011 Jun;23(6):741-7
pubmed: 21293987
Mayo Clin Proc. 2011 Apr;86(4):304-14
pubmed: 21389250
Afr J Prim Health Care Fam Med. 2014 May 15;6(1):E1-7
pubmed: 26245399
J Hum Hypertens. 2017 Jan;31(1):14-21
pubmed: 27306087
Curationis. 2013;36(1):E1-6
pubmed: 26697613
Circ Res. 2019 Mar 29;124(7):1124-1140
pubmed: 30920917
Syst Rev. 2019 May 10;8(1):112
pubmed: 31077247
BMJ. 2008 May 17;336(7653):1114-7
pubmed: 18480115
BMC Public Health. 2019 Mar 25;19(1):341
pubmed: 30909905
Cardiovasc J Afr. 2013 Apr;24(3):67-71
pubmed: 23736129
Prev Med Rep. 2015 Jun 14;2:512-6
pubmed: 26844111
S Afr Med J. 2019 Dec 05;109(11b):3-7
pubmed: 32252860
South Afr J HIV Med. 2015 Jul 02;16(1):367
pubmed: 29568589
S Afr Med J. 2007 Sep;97(9):853-7
pubmed: 17985056
J Res Pharm Pract. 2019 Dec 27;8(4):208-213
pubmed: 31956634
BMC Public Health. 2014 Mar 10;14:240
pubmed: 24606986
J Int AIDS Soc. 2019 Nov;22(11):e25409
pubmed: 31691521
Trop Med Int Health. 2010 Jun;15 Suppl 1:48-54
pubmed: 20586960
Ethn Dis. 2007 Summer;17(3):484-91
pubmed: 17985502
Afr J AIDS Res. 2010 Sep;9(3):235-47
pubmed: 25860628
Patient Educ Couns. 2011 Jun;83(3):310-8
pubmed: 21474263
J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S142-8
pubmed: 17133198
Nat Rev Nephrol. 2020 Apr;16(4):223-237
pubmed: 32024986
J Int AIDS Soc. 2019 Mar;22(3):e25235
pubmed: 30891928
PLoS One. 2015 Oct 08;10(10):e0140298
pubmed: 26447777
Afr J Prim Health Care Fam Med. 2017 Oct 19;9(1):e1-e7
pubmed: 29113443
Soc Sci Med. 2018 Nov;217:18-30
pubmed: 30292072
South Afr J HIV Med. 2016 Sep 30;17(1):476
pubmed: 29568618
J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):196-201
pubmed: 15671805
AIDS. 2010 Jun 1;24(9):1273-80
pubmed: 20453627
AIDS Behav. 2017 Feb;21(2):341-351
pubmed: 27613645
AIDS Care. 2015;27(3):342-9
pubmed: 25559444
BMC Infect Dis. 2019 Sep 5;19(1):775
pubmed: 31488063
BMC Public Health. 2020 Jul 6;20(1):1069
pubmed: 32631300
BMC Public Health. 2009 Jun 05;9:174
pubmed: 19500373
J Am Soc Hypertens. 2011 Jan-Feb;5(1):56-63
pubmed: 21320699
Circulation. 2019 Jan 2;139(1):10-19
pubmed: 30592662
J Comp Eff Res. 2018 Jul;7(7):661-672
pubmed: 29888972
AIDS. 2007 Mar 30;21(6):685-92
pubmed: 17413689
Res Social Adm Pharm. 2009 Dec;5(4):363-75
pubmed: 19962679
Trop Med Int Health. 2018 Mar;23(3):270-278
pubmed: 29243867
BMC Fam Pract. 2015 Jul 03;16:80
pubmed: 26137844
J Acquir Immune Defic Syndr. 2008 Jan 1;47(1):101-7
pubmed: 17971708
Trop Doct. 2015 Oct;45(4):225-30
pubmed: 26002722
J Health Psychol. 2007 May;12(3):444-60
pubmed: 17439995
Arch Intern Med. 2011 Feb 28;171(4):342-50
pubmed: 20975012
AIDS. 2003 Jun 13;17(9):1369-75
pubmed: 12799558
Afr J Prim Health Care Fam Med. 2018 Jun 18;10(1):e1-e8
pubmed: 29943608
PLoS One. 2018 Oct 3;13(10):e0204020
pubmed: 30281618
J Public Health Policy. 2011;32 Suppl 1:S52-64
pubmed: 21730994
Afr J Prim Health Care Fam Med. 2014 Jul 28;6(1):E1-6
pubmed: 26245402